
This week we are looking at a new study on the relationship between aspirin and cancer.
The NHS is set to trial a new blood test designed to detect over 50 types of cancer from next year. A potentially positive development in the future of diagnosing patients with pancreatic cancer.
Following the completion of the Cancer52 survey in June, this blog explores the impact that COVID-19 has had on pancreatic cancer patients and their treatments.
We are thrilled to announced that despite having to postpone many events and initiatives, we are continuing with our vital early diagnosis research. Pancreatic Cancer Action is joining forces with a research team from the University of Surrey, here's more…
Researchers in the USA have published today results from a study of over 4,000 people in which a blood test was shown to accurately detect more than 50 cancer types, often before any symptoms appeared.